Patient is a candidate for treatment with the LINX Reflux Management System

Patient has provided written informed consent for participation in the post-approval study.

Patient has indicated a willingness to comply with study requirements and the follow-up schedule and assessments.

Patient has been diagnosed with GERD as defined by abnormal pH testing.

Patient continues to have chronic GERD symptoms despite maximum medical therapy for the treatment of reflux.

A Post-Approval Study of the LINX® Reflux Management System